AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- Capital expenditures, 2025
- $480K
- YoY, 2025
- +77.8%
- 5-year CAGR
- +59.9%
- 10-year CAGR
- +37.3%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $480K | +77.8% |
| 2024 | $270K | −53.6% |
| 2023 | $582K | −17.1% |
| 2022 | $702K | +127.9% |
| 2021 | $308K | +571.2% |
| 2020 | $46K | +184.7% |
| 2019 | $16K | −50.7% |
| 2018 | $33K | +230.3% |
| 2017 | $10K | −90.5% |
| 2016 | $105K | +417.8% |
| 2015 | $20K | — |